Arphra
live
S&P 5000.34
NASDAQ0.00
DOW50,872.11+2.56%
VIX20.95+16.00%
US10Y4.53+1.21%
EUR/USD1.1576+0.37%
GOLD4,242.2+4.38%
WTI85.83-7.70%
BTC63,338+3.09%
S&P 5000.34
NASDAQ0.00
DOW50,872.11+2.56%
VIX20.95+16.00%
US10Y4.53+1.21%
EUR/USD1.1576+0.37%
GOLD4,242.2+4.38%
WTI85.83-7.70%
BTC63,338+3.09%

KVUE

Kenvue Inc.
Consumer DefensiveHousehold & Personal ProductsUSUSDPeers →
$18.07
LiveJun 11, 2026
AI Brief
Market cap
$34.69B
52w range
14.02 – 22.87
P / E
EPS · FY 2025
$0.76
Volume
8.79M
Revenue · FY 2025
$15.12B
-2.14% YoY

Explain this page

Arphra AI
Business description
· company · SEC profile

Kenvue Inc.

Kenvue Inc. functions as a global leader in the consumer health sector. The company structures its operations across three primary divisions: Self Care, Skin Health and Beauty, and Essential Health. Within the Self Care unit, it offers a diverse range of products for common conditions like coughs, colds, and allergies, in addition to pain relief, digestive health, and smoking cessation aids, featuring prominent brands such as Tylenol, Nicorette, and Zyrtec. The Skin Health and Beauty segment delivers various solutions for facial, body, hair, and sun protection, recognized under popular labels including Neutrogena, Aveeno, and OGX. Moreover, the Essential Health category provides oral hygiene, infant care, feminine wellness, and wound treatment products, marketed through esteemed brands like Listerine, Johnson's, Band-Aid, and Stayfree. Established in 2022, Kenvue Inc. maintains its corporate headquarters in Skillman, New Jersey, and operates as a subsidiary of Johnson & Johnson.

Founded
IPO
May 04, 2023
Employees
22,000
HQ
Summit, NJ
CEO
Kirk L. Perry
CFO
Amit Banati
Exchange
NYSE
Fiscal year